CEFUROXIME News
CEFUROXIME currently has 0 news articles, with 31 predicted indications.
This page combines the AI-predicted indications for CEFUROXIME with the latest health news. Indications highlighted in orange have recent news coverage.
Drug Information
- Evidence level: L5
- Predicted indications (31):
- streptococcal pneumonia (99.0%)
- rhinoscleroma (99.0%)
- streptococcal infection (99.0%)
- impetigo (99.0%)
- arthropathy (99.0%)
- viral meningitis (99.0%)
- bacterial arthritis (99.0%)
- gonorrhea (99.0%)
- maxillary sinusitis (99.0%)
- Lyme disease (99.0%)
- infectious otitis media (99.0%)
- bacterial meningitis (99.0%)
- acute gonococcal endometritis (99.0%)
- acute gonococcal cervicitis (99.0%)
- staphylococcal infection (99.0%)
- staphylococcus aureus infection (99.0%)
- escherichia coli infection (99.0%)
- bacterial pneumonia (99.0%)
- bullous impetigo (99.0%)
- streptococcal meningitis (99.0%)
- staphylococcal pneumonia (99.0%)
- hyperamylasemia (99.8%)
- polyclonal hyperviscosity syndrome (99.8%)
- congenital analbuminemia (99.7%)
- Peptostreptococcus infectious disease (99.7%)
- blood group incompatibility (99.7%)
- urinary tract infection (disease) (99.6%)
- premalignant hematological system disease (99.6%)
- monoclonal gammopathy (99.6%)
- suppurative otitis media (99.6%)
- hematological disease associated with an acquired peripheral neuropathy (99.5%)
Related News (0)
No related news yet. When news mentions this drug, it will be collected and shown here automatically.
Disclaimer: The news on this page is collected automatically and is for research reference only; it does not constitute medical advice.